An investigation of methods to prevent fibrinogen degradation during processing of plasma samples containing the fibrinolytic agents, APSAC and t-PA

This publication has 17 references indexed in Scilit:

• Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: A placebo-controlled arteriographic coronary recanalization study
  Journal of the American College of Cardiology, 1987
• Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator Complex
  Drugs, 1987
• Physiological Balance of Haemostasis and Bleeding
  Drugs, 1987
• Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex
  The American Journal of Cardiology, 1986
• Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation.
  Circulation, 1986
• A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusion
  Blood, 1986
• Clinical effects and kinetic properties of intravenous APSAC — anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction
  International Journal of Cardiology, 1986
• Rapid Lysis of Coronary Artery Thrombi with Anisoylated Plasminogen: Streptokinase Activator Complex
  Annals of Internal Medicine, 1986
• Hemorrhage and the products of fibrinogen digestion after intracoronary administration of streptokinase.
  Circulation, 1984
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
  Acta Haematologica, 1957